Abstract Submission Instructions
Submitting an abstract
- INS Membership is NOT required for abstract submission. INS members who have paid their 2020 dues will receive discounts on registration and continuing education fees.
- Abstracts may be submitted for Paper/Poster or Symposium presentation formats (please see complete details in the section below).
- All abstracts must be submitted in English.
- Standard abbreviations do not need explanation. Otherwise, abbreviations must be defined in brackets after their first use in the text.
Abstracts may only be submitted via this ONLINE FORM
Important Submission Guidelines
- The abstract submission deadline is February 2, 2020. No late submissions will be accepted.
- There is not a late-breaking submission category for this meeting.
- All abstracts must consist of original work. Abstracts submitted to other meetings or that have been previously published should not be submitted and will not be considered.
- All research, results, and conclusions must be final at the time of submission. Abstracts that are promissory in nature will not be considered.
- Case reports may be submitted, but the abstract should clearly describe the uniqueness of the case and how it addresses critical knowledge gaps in the field.
- Abstracts will be published exactly as submitted. Please proofread carefully before finalizing your submission. Once the submission deadline has passed, we will be unable to accommodate any requests for corrections to typos or other entry errors made by the author during submission.
- There is no limitation on the number of submissions, but authors are asked to use discretion because submitting multiple abstracts is likely to create scheduling problems.
- Accepted abstracts may be scheduled at any time during the three-day meeting at the discretion of the Program Co-Chairs.
By submitting, authors commit to be available to present on the date and time they are assigned.
- All submissions will be peer reviewed by the Program Committee. The Program Committee Co-Chairs will make the final decision on all submissions.
- The body of the abstract may not exceed 2000 characters, including spaces. Paper or Poster submissions should be organized under the following four headings: Objective, Participants and Methods, Results, and Conclusions.
- An automatically generated confirmation will be sent to the email address of the corresponding author after an abstract submission. If you will not receive it within one hour (and it will not be either in your spam folder), please contact us at email@example.com.
- If changes to your submitted abstract are necessary, please contact us at email address above, any time before the abstract submission deadline. Please do not submit your abstract more than once.
- Accepted abstracts must be presented by the designated presenting author or by their representative (the submitting author must formally communicate any changes in the presenting author to INS at firstname.lastname@example.org). Presenters and any authors who will attend the meeting must register for the meeting and pay the appropriate fee.
- Authors will be notified of the acceptance or non-acceptance of their abstracts by email by April 13, 2020.
- Please note that registration of the presenting author is mandatory. The deadline for the presenting author’s registration and payment is May 21, 2020.
If the presenting author has not registered and has not completed the payment of registration fee by this date, the presentation will be withdrawn from the program.
Publication of Abstracts
Abstracts that are accepted and presented at the meeting will be published in an online, supplemental issue of the Journal of the International Neuropsychological Society: JINS.
Available Presentation Formats
1. Poster sessions: The poster format has proven to be an effective and popular method for communication of scientific information. Poster sessions will be designed to provide a more intimate forum for informal discussion than is permitted by regular platform presentations. Poster presenters will stay with their poster for the duration of the poster session (approximately 60–90 minutes). Presenters are encouraged to upload a PDF of their poster to the meeting app for interested viewers.
2. Paper sessions: Paper sessions are topical oral sessions that are arranged at the discretion of the INS Program Committee Co-Chairs. Four to six individually submitted abstracts will be chosen for each paper session. Each abstract will be allotted 12–15 minutes for oral presentation and audience discussion. A moderator will adhere to these time limits to allow time for discussion among the presenters and the audience.
3. Symposia: Symposia are topical platform sessions that deal with specific issues in clinical neuropsychology. INS symposia are distinct from other abstract submissions in that symposia proposals are submitted as an integrated session proposal (usually consisting of 4–5 abstracts) that has been pre-organized by the chair of the proposed symposium session.
- A complete symposium proposal consists of a Summary Symposium Abstract (Description of the Symposium), plus a maximum of four Participating Symposium Abstracts (submitted by co-authors or on their behalf by the chair via the special link which will be sent by email after the Summary Symposium Abstract submission). Symposium proposals that do not meet these criteria may not be considered.
- All symposium abstracts should be closely linked and integrated. Symposia are allotted approximately 90 minutes, so each participating abstract should be given approximately 15–20 minutes. Each symposium should include a review led by the symposium organizer or a discussant (which should correspond to the Summary Abstract), as well as a dedicated question and answer period. In the case of a symposium that expresses divergent views on a controversial topic, two longer debate-style talks may also be appropriate.
- The symposium chair is SOLELY responsible for submitting the complete symposium proposal as described.
Available Submission Categories
- Acquired Brain Injury (TBI/Cerebrovascular Injury & Disease – Adult)
- Acquired Brain Injury (TBI/Cerebrovascular Injury & Disease – Child)
- ADHD/Attentional Functions
- Assessment/Psychometrics/Methods (Adult)
- Assessment/Psychometrics/Methods (Child)
- Autism Spectrum Disorders/Intellectual Disability
- Behavioral Neurology/Cerebral Lateralization/Callosal Studies
- Career Development/Education/Training
- Cognitive Intervention/Rehabilitation
- Cognitive Neuroscience
- Concussion/Mild TBI (Adult)
- Concussion/Mild TBI (Child)
- Dementia (Alzheimer's Disease)
- Dementia (Non-AD)
- Drug/Toxin-Related Disorders (including Alcoholism)
- Emotion Regulation
- Emotional and Social Processes
- Executive Functions/Frontal Lobes
- Forensic Neuropsychology/Malingering/Noncredible Presentations
- Genetics/Genetic Disorders
- HIV/AIDS/Infectious Disease
- Inclusion and Diversity/Multiculturalism
- Infectious Disease/Encephalitis/Meningitis (including HIV/AIDS)
- Language and Speech Functions/Aphasia
- Learning Disabilities/Academic Skills
- MCI (Mild Cognitive Impairment)
- Medical/Neurological Disorders/Other (Adult)
- Medical/Neurological Disorders/Other (Child)
- Memory Functions/Amnesia
- Mood & Anxiety Disorders
- Movement and Movement Disorders
- Multiple Sclerosis/ALS/Demyelinating Disorders
- Prematurity/Low Birth Weight/In Utero Teratogen Exposure
- Stroke/Cerebrovascular Injury & Disease (Adult)
- Stroke/Cerebrovascular Injury & Disease (Child)
- Stroke/Vascular Cognitive Impairment
- TBI (Moderate-Severe; Adult)
- TBI (Moderate-Severe; Child)
- Visuospatial Functions/Neglect/Agnosia